Vanderbilt researchers report that social media posts can offer insights into how the public feels about genome editing, with stances varying across platforms and differing from those of academics and policy makers.

Topical treatment of burns with an immunosuppressive drug counteracted the negative effects of aging on wound healing, Vanderbilt researchers have discovered.

Renowned developmental geneticist Ruth Lehmann, PhD, is the recipient of the 2022 Vanderbilt Prize in Biomedical Science.

Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows.

A study comparing 618 military veterans who deployed to a combat zone after Sept. 11, 2001, and 2,099 health care workers (HCWs) working during the COVID-19 pandemic found similar levels of potential moral injury (PMI), with 46.1% of veterans and 50.7% of HCWs reporting PMI.

Starting on April 4, Vanderbilt providers initiated the “Randomized Trial of Sedative Choice for Intubation” (RSI) study to determine whether ketamine or etomidate is better for preventing low blood pressure, low oxygen levels, serious heart problems, or even death for severely ill patients undergoing intubation.

Prior authorization — health insurer approval of a medical intervention prior to treatment — costs more than $40 million for U.S. academic radiation oncology practices, with questionable value added to patient care.